Idexx Laboratories IDXX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total Revenue by Business | |||||
| CAG | $3.95B+10.6% | $3.57B+6.6% | $3.35B+9.6% | $3.06B+5.8% | |
| LPD | $131.79M+8.0% | $122.06M+0.3% | $121.66M-0.8% | $122.61M-9.8% | |
| Water segment revenue | $201.15M+8.7% | $185.11M+10.1% | $168.15M+8.0% | $155.72M+6.3% | |
| Gross Profit by Business | |||||
| CAG | $2.45B+12.4% | $2.18B+8.8% | $2B+10.8% | $1.81B— | |
| LPD | $64.21M+2.6% | $62.56M-4.4% | $65.44M-10.4% | $73M— | |
| Water segment revenue | $139.29M+7.1% | $130.01M+12.1% | $116M+5.6% | $109.86M— | |
| Cost of revenue by Business | |||||
| CAG | $1.5B+7.9% | $1.39B+3.3% | $1.35B+7.8% | $1.25B— | |
| LPD | $67.58M+13.6% | $59.5M+5.8% | $56.22M+13.3% | $49.61M— | |
| Water segment revenue | $61.86M+12.3% | $55.1M+5.7% | $52.15M+13.7% | $45.86M— | |
| Goodwill, Foreign Currency Translation, Gain (Loss) by Business | |||||
| CAG | $7.47M+249% | -$5.03M-284% | $2.74M+151% | -$5.33M-49.3% | |
| LPD | $1.63M+209% | -$1.51M-236% | $1.11M+517% | $179K+126% | |
| Water segment revenue | $298K+373% | -$109K-134% | $321K+136% | -$897K-968% | |
| D&A by Business | |||||
| CAG | $130.35M+12.1% | $116.28M+12.3% | $103.55M+2.3% | $101.25M+7.5% | |
| LPD | $4.04M+6.3% | $3.8M+4.0% | $3.66M-3.7% | $3.8M-2.8% | |
| Water segment revenue | $4.76M+0.5% | $4.73M+15.0% | $4.12M+36.3% | $3.02M+11.5% | |
| Total Revenue by Product | |||||
| CAG Diagnostics capital - instruments | $200.21M+51.8% | $131.93M-4.1% | $137.6M-6.6% | $147.33M-1.2% | |
| Rapid assay products | $348.95M-3.0% | $359.75M+4.4% | $344.49M+9.8% | $313.67M+5.7% | |
| Recurring revenue | $276.34M+10.4% | $250.36M+16.7% | $214.6M+18.6% | $180.97M+22.7% | |
| Reference laboratory diagnostic and consulting services | $1.42B+6.6% | $1.34B+4.5% | $1.28B+8.5% | $1.18B+4.8% | |
| Systems and hardware | $69.54M+11.7% | $62.27M-3.8% | $64.73M-7.8% | $70.21M+19.5% | |
| Cost of revenue by Product | |||||
| Product revenue | $804.62M+12.4% | $716.08M-0.3% | $717.95M+9.4% | $656.51M0.0% | |
| Service revenue | $839.51M+4.6% | $802.5M+6.6% | $753.03M+6.6% | $706.48M+5.6% | |
| Revenue, remaining performance obligation (as a percent) by Product | |||||
| Customer commitment arrangements, multi-year arrangements | 106%0.0pp | 106%— | —— | —— | |
| Extended warranties and post contract support | 151%+2.0pp | 149%— | —— | —— | |
| Reagent rental arrangements | 105%+3.0pp | 102%— | —— | —— | |
| Rebate and up-front considerations arrangements | 114%-10.0pp | 124%— | —— | —— | |
| Revenue by Product | |||||
| CAG Diagnostics services and accessories | $137.42M+5.4% | $130.37M+5.1% | $124.05M+11.5% | $111.26M+3.7% | |
| IDEXX VetLab consumables | $1.5B+14.8% | $1.3B+9.7% | $1.19B+12.4% | $1.06B+5.0% | |
| Estimation of future revenues by Product | |||||
| Customer commitment arrangements, multi-year arrangements | $19.1B+15.1% | $16.6B— | —— | —— | |
| Extended warranties and post contract support | $36.4M0.0% | $36.4M— | —— | —— | |
| Reagent rental arrangements | $311.7M+17.6% | $265.1M— | —— | —— | |
| Total consolidated revenue by Geography | |||||
| Australia | $112.25M+10.1% | $101.96M+6.8% | $95.47M-1.0% | $96.41M+2.1% | |
| China | $35.96M+0.4% | $35.82M-18.9% | $44.17M-10.2% | $49.19M-22.1% | |
| France | $126M+13.7% | $110.8M+14.5% | $96.8M+14.6% | $84.48M-7.0% | |
| Germany | $206.76M+19.0% | $173.68M+16.0% | $149.79M+8.6% | $137.88M-6.1% | |
| Italy | $66.86M+14.8% | $58.22M+8.2% | $53.79M+11.6% | $48.19M-7.4% | |
| Japan | $83.36M+14.0% | $73.14M-3.2% | $75.57M-2.7% | $77.66M-7.8% | |
| Latin America & Caribbean | $90.41M+8.0% | $83.69M-0.3% | $83.92M+11.8% | $75.04M+12.6% | |
| Netherlands | $40.5M+19.0% | $34.05M+11.6% | $30.51M+13.5% | $26.88M-9.4% | |
| Other | $124.36M+13.0% | $110.1M+5.8% | $104.11M+8.1% | $96.29M-42.5% | |
| Spain | $70.97M+14.7% | $61.86M+18.2% | $52.33M+11.4% | $46.98M-2.5% | |
| Switzerland | $41.7M+12.1% | $37.18M+6.8% | $34.83M+13.7% | $30.65M-4.2% | |
| United Kingdom | $154.44M+14.7% | $134.63M+10.6% | $121.75M+10.3% | $110.4M-4.0% | |
| Total Revenue by Geography | |||||
| Asia Pacific | $355.93M+10.9% | $321.02M+0.5% | $319.31M-0.1% | $319.55M-3.6% | |
| Canada | $167.33M+9.4% | $152.89M+1.8% | $150.11M+5.2% | $142.74M+2.2% | |
| Europe, the Middle East and Africa | $937.25M+16.2% | $806.73M+12.6% | $716.18M+10.7% | $647.03M-5.1% | |
| United States | $2.75B+8.7% | $2.53B+5.9% | $2.39B+9.5% | $2.18B+9.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Idexx Laboratories break its business down?
- Idexx Laboratories (IDXX) reports total revenue by business across 3 parts — CAG, LPD and Water segment revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Idexx Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Idexx Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
